Studies on middle-aged DS patients have confirmed that chronic overexpression of S100β contributes to increased neuronal and neuritic APP expression with consequent accelerated amyloid deposition, as well as abnormal growth of neurites in β-amyloid plaques [37,49]. This evidence concerns the gene APP and Dravet syndrome.